comparemela.com

Latest Breaking News On - Chief rd officer - Page 7 : comparemela.com

Viatris Continues its Preparations for Phase 2 of its Strategic Plan by Announcing the Appointment of Theodora "Doretta" Mistras as Chief Financial Officer, Effective March 1, 2024, and Philippe Martin as Chief R&D Officer

Company thanks Sanjeev Narula for his role in the successful execution of Viatris Phase 1 strategy; Narula will support a smooth CFO transition prior to his departure on March 1, 2024 PITTSBURGH,.

Shanghai
China
India
Hyderabad
Andhra-pradesh
Sanjeev-narula
Theodora-doretta-mistras
Scotta-smith
Centocor-johnson
Philippe-martin
Goldman-sachs
Doretta-mistras

Groundbreaking methane alliance established at COP28

Groundbreaking methane alliance established at COP28
airqualitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from airqualitynews.com Daily Mail and Mail on Sunday newspapers.

Dubai
Dubayy
United-arab-emirates
Kraft-heinz
Alastair-collier
Bel-group
Nestle
Danone
Lactalis-united-states
Chief-rd-officer

Vivodyne Announces $38 Million Seed Financing Led by Khosla Ventures to Develop Lab-Grown Human Organs

Vivodyne Announces $38 Million Seed Financing Led by Khosla Ventures to Develop Lab-Grown Human Organs
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Alex-morgan
Andrei-georgescu
Alex-andrianopoulos
Dan-huh
Thomas-cantrell
University-of-pennsylvania
Khosla-ventures
Kairos-ventures
Chief-commercial-officer
Susan-billings
Chief-rd-officer
Nature-methods

Vivodyne Announces $38 Million Seed Financing Led by Khosla Ventures to Develop Lab-Grown Human Organs

Vivodyne, a biotech that discovers and develops more effective drugs by testing them on lab-grown human organs, today announced the close of $38 million in total seed financing, led by Khosla Ventures, with participation from Kairos Ventures, CS.

Dan-huh
Alex-andrianopoulos
Andrei-georgescu
Alex-morgan
Khosla-ventures-to-develop-lab
University-of-pennsylvania
Seed-financing-led
Khosla-ventures
Develop-lab-grown-human
Kairos-ventures
Susan-billings
Chief-commercial-officer

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2023 Earnings Call Transcript

Operator: Good morning, and welcome to the BioXcel Therapeutics Conference Call, which will cover its alignment with the FDA on its TRANQUILITY program, provide an update on strategic financing, and review.

Qatar
United-states
Philadelphia
Pennsylvania
White-house
District-of-columbia
America
Matt-wiley
Vince-oneill
Canaccord-genuity
Vimal-mehta
Frank-yocca

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.